Dr Ross A Metzman, MD | |
6 E Chestnut St, Mgmc Pathology, Augusta, ME 04330-5717 | |
(207) 626-1409 | |
Not Available |
Full Name | Dr Ross A Metzman |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 6 E Chestnut St, Augusta, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205902608 | NPI | - | NPPES |
304340099 | Medicaid | ME | |
M55183 | Other | ME | CIGNA |
1041556 | Other | ME | AETNA |
019760 | Other | ME | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 013649 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ross A Metzman, MD 6 E. Chestnut St., Mgmc Pathology, Augusta, ME 04330 Ph: (207) 626-1409 | Dr Ross A Metzman, MD 6 E Chestnut St, Mgmc Pathology, Augusta, ME 04330-5717 Ph: (207) 626-1409 |
News Archive
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas.
Scientists now believe that the Fountain of Youth flows from our genes, or at least from the genes of people who live healthy lives to age 100 or later.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.
Results of a study on Breast-Specific Gamma Imaging (BSGI) presented at the annual breast meeting of the American Society of Clinical Oncology in Washington, D.C., showed that BSGI was nearly twice as effective in finding cancers and more than three times as likely to lead to the correct diagnosis when compared to ultrasound.
› Verified 5 days ago
Dr. Carol Anne Saunders, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Dept Of Pathology, Augusta, ME 04330 Phone: 207-626-1409 Fax: 207-626-1046 | |
Liam Eirik Funte, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 30 Hospital Street, Ocme, Augusta, ME 04330 Phone: 207-624-7185 | |
Cheri Lynn Aubertine, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1410 | |
John Joseph Oprendek Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1409 Fax: 207-626-1046 | |
Vincent Gemellaro, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Laboratory 113, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-7314 | |
Laura Lee Nelsen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 605-670-9580 |